Related Experiment Video
Updated: Jan 20, 2026

Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
Youlian Zhou1,2, Haoming Xu1,2, Hongli Huang1,2
1Department of Gastroenterology, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China.
Abstract:
Intestinal microbial dysbiosis is associated with various intestinal and extraintestinal disorders. Fecal microbiota transplantation (FMT), a type of fecal bacteriotherapy, is considered an effective therapeutic option for recurrent Clostridium difficile infection (rCDI) and also has important value in other intestinal diseases including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). The purpose of this review is to discuss promising therapeutic value in extraintestinal diseases associated with gut microbial dysbiosis, including liver, metabolic, chronic kidney, neuropsychiatric, allergic, autoimmune, and hematological diseases as well as tumors.
Related Concept Videos
07:32Murine Fecal Isolation and Microbiota Transplantation
05:41Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
03:33Evaluating the Effects of Fecal Microbiota Transplantation in an Interleukin-10 Deficient Mouse
07:06Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
05:28Analysis of Fecal Microbiota Dynamics in Lupus-Prone Mice Using a Simple, Cost-Effective DNA Isolation Method

